Cerebral infarction following intravenous immunoglobulin therapy for Guillain-Barre syndrome
Journal of Stroke and Cerebrovascular Diseases, vol.10, no.6, pp.290-292, 2001 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 10 Issue: 6
- Publication Date: 2001
- Doi Number: 10.1053/jscd.2001.123772
- Journal Name: Journal of Stroke and Cerebrovascular Diseases
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.290-292
- Keywords: Cerebral infarction, Guillain-Barre syndrome, Intravenous immunoglobulin
- Karadeniz Technical University Affiliated: Yes
Abstract
Intravenous immunoglobulin (IvIg) therapy is used increasingly for different immune-mediated diseases, such as the Guillain-Barre syndryyome. We report the case of a 55-year-old man who developed a cerebral infarction 2 days after completion of treatment with intravenous immunoglobulin for Guillain-Barre syndrome. Copyright © 2001 by National Stroke Association.